Aktie A007570 ILYANG PHARMACEUTICAL CO.,LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Ilyang Pharmaceutical Co.,Ltd

Aktien

A007570

KR7007570005

A007570

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 14.05.2024 		% 5 Tage % 1. Jan.
13.900 KRW +0,22 % Intraday Chart für Ilyang Pharmaceutical Co.,Ltd +0,72 % -11,18 %
2023 Ilyang Pharmaceutical Co.,Ltd meldet Ergebnis für das erste Quartal zum 31. März 2023 CI
2023 Ilyang Pharmaceutical Co.,Ltd (KOSE:A007570) kündigt einen Aktienrückkauf im Wert von 2.000 Millionen KRW an. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.
Ilyang Pharmaceutical Co.,Ltd's Equity Buyback announced on April 6, 2023, has expired with 115,080 shares, representing 0.63% for KRW 1,999.72 million.
Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.
Ilyang Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Ilyang Pharmaceutical Co.,Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.
Ilyang Pharmaceutical Co.,Ltd authorizes a Buyback Plan.
Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on March 10, 2022.
Ilyang Pharmaceutical Co.,Ltd's Equity Buyback announced on March 10, 2022, has expired with 118,321 shares, representing 0.65% for KRW 2,859.89 million.
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine
Ilyang Pharmaceutical Co.,Ltd announces an Equity Buyback for KRW 3,000 million worth of its shares.
Ilyang Pharmaceutical Co.,Ltd authorizes a Buyback Plan.
Ilyang Pharmaceutical Co.,Ltd(KOSE:A007570) dropped from KOSPI 200 Index
Boryung Pharmaceutical : S.Korea sticks to flu vaccine plan despite safety fears after 25 die
Boryung Pharmaceutical : Number of South Koreans dying after flu shot rises, prompts vaccine worries
Il-Yang Pharmaceutical Signs Licence with Laboratorios Biopas to Export Leukemia Drug Supect to Colombia
Ilyang Pharmaceutical Co., Ltd announced that it has received KRW 30 billion in funding from Hana Daetoo Securities Co., Ltd., Investment Arm, Hanyang Securities Co. Ltd., Investment Arm, Hungkuk Life Insurance Co., Ltd., Korea Securities Finance Corporation, Investment Arm, KTB Investment & Securities Co.,Ltd., and SBI Savings Bank Inc., Investment Arm.
Ilyang Pharmaceutical Co., Ltd announced that it expects to receive KRW 30 billion in funding from Hana Daetoo Securities Co., Ltd., Investment Arm, Hanyang Securities Co. Ltd., Investment Arm, Hungkuk Life Insurance Co., Ltd., Korea Securities Finance Corporation, Investment Arm, KTB Private Equity, and SBI Savings Bank Inc., Investment Arm.
Ilyang Pharmaceutical Co., Ltd's Equity Buyback Plan Extended till September 25, 2022.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A007570 Aktie
  4. Nachrichten Ilyang Pharmaceutical Co.,Ltd
  5. Andere Sprachen